'Piloting a framework for analysing the public contributions to R&D: new antibiotics in focus'.

ABSTRACT:

Background

Within the context of increasing transparency around public contributions, a framework for reporting and analysing public contributions to research and development (R&D) was previously developed and is piloted here using the example of antibiotics. The aim of this work is to check whether the category system is feasible, to revise and adjust the granularity of the category system where necessary, and to expand the range of sources for detailed analyses.

Methods

All antimicrobial medicinal products in development, discontinued and approved in the last 10 years were identified in the literature. Thereafter clinical trials and company information was searched generating a list of 56 compounds where primarily small to medium-sized enterprises (SMEs) were involved in a

SUBMITTER: Schmidt L 

PROVIDER: S-EPMC11753009 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature